Inventor · disambiguated record
Marlon Rebelatto
Also filed as: REBELATTO MARLON · REBELATTO MARLON C
7 granted patents·5 pending applications·23 citations·filing 2012–2023
80Inventor score
Top patents by PatentIndex Score
12 records- 0187US9220775B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Dec 29, 2015·15 cites·39 claims
- 0285US10829557B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2019·Granted Nov 10, 2020·2 cites·9 claims
- 0379US10040857B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 7, 2018·3 cites·56 claims
- 0476US10336823B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2014·Granted Jul 2, 2019·3 cites·18 claims
- 0569US11827706B2Anti-B7-H1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2020·Granted Nov 28, 2023·0 cites·20 claims
- 0668US2022332828A1Anti-pd-l1 antibody treatment of bladder cancerMEDIMMUNE LLC·Filed 2022·Application pending·0 cites
- 0765US11091554B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2018·Granted Aug 17, 2021·0 cites·20 claims
- 0861US2024150469A1Anti-b7-h1 antibodies for treating tumorsMEDIMMUNE LTD·Filed 2023·Application pending·0 cites
- 0955US2019359715A1Anti-pd-l1 antibody treatment of bladder cancerMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 1052US11305012B2Binding molecules specific for HER3 and uses thereofMEDIMMUNE LLC·Filed 2014·Granted Apr 19, 2022·0 cites·14 claims
- 1131US2016031990A1Antagonists of pdl-1 and pd-1 for the treatment of hpv-negative cancersMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
- 1229US2016060344A1Combination therapy for pd-l1 negative tumorsNARWAL RAJESH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marlon Rebelatto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →